Focused Ultrasound Blood-Brain-Barrier Opening

0
11
The authors demonstrate that FOXA2 bound distinct classes of developmental enhancers in multiple androgen receptor-independent prostate cancer subtypes, with its binding depending on LSD1.
[Nature Communications]
Full Article